Electromed (ELMD) Other Non-Current Liabilities (2018 - 2026)

Electromed (ELMD) posted quarterly Other Non-Current Liabilities of $81000.0 for Q1 2026, down 15.62% quarter-over-quarter from $96000.0 in Q4 2025.

Electromed (ELMD) Other Non-Current Liabilities (2018 - 2026) Analysis & Trends

Electromed (ELMD) has reported Other Non-Current Liabilities for 9 consecutive years, with $81000.0 the latest figure, recorded in Q1 2026.

In Q1 2026, Other Non-Current Liabilities changed N/A year-over-year to $81000.0; the TTM figure through Mar 2026 stood at $81000.0 (changed N/A YoY), while the FY2025 annual figure was $125000.0, up 941.67% from the prior year.
Other Non-Current Liabilities eased to $81000.0 in Q1 2026 per ELMD's latest filing, from $96000.0 in the prior quarter.
Across five years, Other Non-Current Liabilities topped out at $396000.0 in Q3 2024 and bottomed at $4000.0 in Q4 2024.
Historically, Other Non-Current Liabilities has averaged $77625.0 across 5 years, with a median of $46000.0 in 2022.
Annual changes were most pronounced in 2024 — Other Non-Current Liabilities tumbled 91.84% — and 2025, when it surged 2300.0%.
Electromed's Other Non-Current Liabilities stood at $33000.0 in 2022, then soared by 48.48% to $49000.0 in 2023, then sank by 91.84% to $4000.0 in 2024, then soared by 2300.0% to $96000.0 in 2025, then dropped by 15.62% to $81000.0 in 2026.
Business Quant data shows ELMD's Other Non-Current Liabilities at $81000.0 in Q1 2026, $96000.0 in Q4 2025, and $110000.0 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn
10	Electromed	327.63 Mn	310.64 Mn	14.64 Mn

Download Data